Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 14, 2020 09:28 ET | Source: Liquidia Technologies, Inc.

Liquidia Corporation Announces Chief Executive Officer Transition

RESEARCH TRIANGLE PARK, N.C., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced Damian deGoa has been appointed as Chief Executive Officer (CEO) and a director of...
November 30, 2020 07:15 ET | Source: Liquidia Technologies, Inc.

Liquidia Corporation Appoints Michael Kaseta Chief Financial Officer

RESEARCH TRIANGLE PARK, N.C., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced Michael Kaseta has been appointed Chief Financial Officer (CFO), effective...
November 25, 2020 07:00 ET | Source: Liquidia Technologies, Inc.

Liquidia Receives Complete Response Letter from FDA for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial Hypertension

CRL does not cite need for additional clinical studies CRL focuses on drug CMC and device biocompatibility information Conference Call Scheduled for Today at 9:00a.m. ET RESEARCH TRIANGLE PARK,...
November 18, 2020 16:01 ET | Source: Liquidia Technologies, Inc.

Liquidia Closes Acquisition of RareGen

Merger Reinforces Company’s Commitment to Patients with PAH Paul Manning and Roger Jeffs Join Liquidia Corporation Board of Directors RESEARCH TRIANGLE PARK, N.C., Nov. 18, 2020 (GLOBE...
November 16, 2020 07:15 ET | Source: Liquidia Technologies, Inc.

Liquidia Announces Results of Special Meeting of Stockholders

Stockholders Approve RareGen Acquisition Merger Expected to Close on or About November 18, 2020 RESEARCH TRIANGLE PARK, N.C., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc....
November 12, 2020 10:06 ET | Source: Liquidia Technologies, Inc.

Liquidia to Present at the 2020 Jefferies Virtual London Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused on the development and...
November 09, 2020 07:15 ET | Source: Liquidia Technologies, Inc.

Liquidia Reports Third Quarter 2020 Financial Results and Provides Corporate Update

- Raised $75 Million through Underwritten Public Offering- Bolstered and Defended LIQ861 Patent Position- Advanced Efforts in Support of the RareGen, LLC Merger and Integration- Company to Host...
November 02, 2020 07:15 ET | Source: Liquidia Technologies, Inc.

Liquidia Reschedules Special Meeting of Stockholders and Reaffirms Recommendation to Approve Proposed Acquisition of RareGen, LLC

Company Determines Unsolicited Offer does not Constitute Superior Proposal RESEARCH TRIANGLE PARK, N.C, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (NASDAQ: LQDA), a late-stage...
October 30, 2020 20:40 ET | Source: Liquidia Technologies, Inc.

UPDATE – Liquidia to Report Third Quarter 2020 Financial Results and Provide Corporate Update on November 6, 2020

RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq:LQDA), a late-stage clinical biopharmaceutical company focused on the development and...
October 30, 2020 16:15 ET | Source: Liquidia Technologies, Inc.

Liquidia to Report Third Quarter 2020 Financial Results and Provide Corporate Update on November 6, 2020

RESEARCH TRIANGLE PARK, N.C., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Liquidia Technologies, Inc. (Nasdaq:LQDA), a late-stage clinical biopharmaceutical company focused on the development and...